Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gregor Adams

Showing results (1-10 of 2) with videos related to

Pageof 1
Sort By:
Discovery Medicine|August 14, 2010
Defining the hematopoietic stem cell nicheGregor Adams, David Scadden
Toxicological Sciences : an Official Journal of the Society of Toxicology|June 27, 2020
Nonclinical Safety Assessment of AMG 553, an Investigational Chimeric Antigen Receptor T-Cell Therapy for the Treatment of Acute Myeloid LeukemiaChristine Karbowski, Rebecca Goldstein, Brendon Frank, et al.
Pageof 1

Showing results (1-10 of 2) with videos related to

Sort By:
Pageof 1
Discovery Medicine|August 14, 2010
Defining the hematopoietic stem cell nicheGregor Adams, David Scadden
Toxicological Sciences : an Official Journal of the Society of Toxicology|June 27, 2020
Nonclinical Safety Assessment of AMG 553, an Investigational Chimeric Antigen Receptor T-Cell Therapy for the Treatment of Acute Myeloid LeukemiaChristine Karbowski, Rebecca Goldstein, Brendon Frank, et al.
Pageof 1